InsidersTradesSigma
Browse the complete record of transactions filed by Brenner Randall B., Dirigeant. Director active across 1 companies, notably Paratek Pharmaceuticals, Inc.. Aggregated, 7 disclosures have been logged. Total volume traded: €35k. The latest transaction was disclosed on 15 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
7 of 7 declarations
Randall B. Brenner is associated with Paratek Pharmaceuticals, Inc. Although his specific role is not detailed, he contributes to the leadership and strategy of the company. Brenner is involved in initiatives that support the company's objectives in the pharmaceutical sector.